#### 48A biotech startup receives $250,000 in seed funding from an angel investor. They allocate 40% to genetic sequencing research, 30% to lab equipment, and the remainder to personnel and operations in a 2:3 ratio. How much money is allocated to personnel? - Decision Point

Understanding the Context

Following the investment, the startup’s capital is distributed as follows:

• 40% to genetic sequencing research
  
• 30% to lab equipment purchases
  
• Remaining 30% split between personnel and operations in a 2:3 ratio

Let’s break down the exact figures:

• Genetic sequencing research: $250,000 × 40% = $100,000
  
• Lab equipment: $250,000 × 30% = $75,000
  
• Remaining funds: $250,000 – $100,000 – $75,000 = $75,000

This $75,000 is allocated between personnel and operations, with a 2:3 ratio favoring operations. These funds cover salaries, training, administrative costs, and facility management.

To determine the exact personnel portion:
The ratio 2:3 means 2 parts for personnel and 3 parts for operations, totaling 5 parts.

• Personnel allocation: ($75,000 ÷ 5) × 2 = $30,000

Key Insights

Why This Matters

This strategic distribution underscores the startup’s focus on both science and scaling. While critical research receives substantial funding, investing in skilled personnel ensures high-quality outcomes and operational efficiency. The 2:3 split prioritizes robust operations—vital for managing lab workflows, data management, and regulatory compliance—while deeply supporting expert talent.

For biotech investors, this transparent breakdown highlights sound financial planning, turning seed capital into tangible progress in genetic innovation.

Conclusion
Out of the $250,000 seed round, $30,000 is allocated to personnel, empowering the startup’s team to drive its genetic sequencing ambitions forward with precision and sustainability.

Final Thoughts

Discover how targeted biotech investments are accelerating life-changing innovations—subscribe for updates on emerging startups and science funding.